Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance (Q39977681)

16 September 2017

Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance (English)

1 reference

16 September 2017

1 reference

1 reference

1 reference

Hong Joo Kim

1

1 reference

16 September 2017

Jung Ho Park

2

1 reference

16 September 2017

Dong Il Park

3

1 reference

16 September 2017

Yong Kyun Cho

4

1 reference

16 September 2017

Chong Il Sohn

5

1 reference

16 September 2017

Woo Kyu Jeon

6

1 reference

16 September 2017

Byung Ik Kim

7

1 reference

16 September 2017

30 June 2009

1 reference

16 September 2017

1 reference

16 September 2017

3

1 reference

16 September 2017

108-115

1 reference

16 September 2017

2

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

16 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Association of diabetes mellitus and chronic hepatitis C virus infection.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Excess risk of primary liver cancer in patients with diabetes mellitus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Excessive serum insulin response to oral glucose in obesity and mild diabetes. Study of 501 patients.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Effect of interferon on glucose tolerance and insulin sensitivity.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Correlation between insulin resistance and hepatitis C viral load

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Extrahepatic manifestations and insulin resistance in an HCV hyperendemic area.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852696

Interferon induces insulin resistance in patients with chronic active hepatitis C

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20431732

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20431732

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20431732

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5009/GNL.2009.3.2.108

1 reference

16 September 2017

1 reference

16 September 2017

1 reference